These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29968429)

  • 1. White-Coat Hypertension: the Neglected Subgroup in Hypertension.
    Cuspidi C; Tadic M; Mancia G; Grassi G
    Korean Circ J; 2018 Jul; 48(7):552-564. PubMed ID: 29968429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage.
    Mancia G; Facchetti R; Vanoli J; Dell'Oro R; Seravalle G; Grassi G
    Hypertension; 2022 May; 79(5):1057-1066. PubMed ID: 35191312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).
    Sega R; Trocino G; Lanzarotti A; Carugo S; Cesana G; Schiavina R; Valagussa F; Bombelli M; Giannattasio C; Zanchetti A; Mancia G
    Circulation; 2001 Sep; 104(12):1385-92. PubMed ID: 11560854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020.
    Mancia G; Facchetti R; Bombelli M; Cuspidi C; Grassi G
    Hypertension; 2021 Dec; 78(6):1677-1688. PubMed ID: 34757765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Coat Hypertension: to Treat or Not to Treat?
    Cuspidi C; Sala C; Grassi G; Mancia G
    Curr Hypertens Rep; 2016 Nov; 18(11):80. PubMed ID: 27787835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.
    Sega R; Facchetti R; Bombelli M; Cesana G; Corrao G; Grassi G; Mancia G
    Circulation; 2005 Apr; 111(14):1777-83. PubMed ID: 15809377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.
    Mancia G; Bombelli M; Lanzarotti A; Grassi G; Cesana G; Zanchetti A; Sega R
    Arch Intern Med; 2002 Mar; 162(5):582-6. PubMed ID: 11871927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.
    Mancia G; Carugo S; Grassi G; Lanzarotti A; Schiavina R; Cesana G; Sega R;
    Hypertension; 2002 Mar; 39(3):744-9. PubMed ID: 11897756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.
    Mancia G; Facchetti R; Bombelli M; Grassi G; Sega R
    Hypertension; 2006 May; 47(5):846-53. PubMed ID: 16567588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
    Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
    Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    Bombelli M; Maloberti A; Raina L; Facchetti R; Boggioni I; Pizzala DP; Cuspidi C; Mancia G; Grassi G
    J Hypertens; 2016 Sep; 34(9):1823-30. PubMed ID: 27348518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the cardiovascular outcomes of participants with white-coat hypertension poor compared to those of participants with normotension? A systemic review and meta-analysis.
    Fujiwara T; Matsumoto C; Asayama K; Ohkubo T; Hoshide S
    Hypertens Res; 2019 Jun; 42(6):825-833. PubMed ID: 30971805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study.
    Grassi G; Vanoli J; Facchetti R; Mancia G
    Curr Hypertens Rep; 2022 Feb; 24(2):29-35. PubMed ID: 35076878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality.
    Bombelli M; Ronchi I; Volpe M; Facchetti R; Carugo S; Dell'oro R; Cuspidi C; Grassi G; Mancia G
    J Hypertens; 2014 Jun; 32(6):1237-44. PubMed ID: 24675682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Grassi G; Sega R
    J Hypertens; 2009 Aug; 27(8):1672-8. PubMed ID: 19417688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
    Mancia G; Facchetti R; Grassi G; Bombelli M
    Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of sustained hypertension in white-coat or masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
    Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2017 Mar; 35(3):506-512. PubMed ID: 27926692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.